It has to be underlined that both on blood and on tumor tissue BRCA1/2 testing should be cautionary performed, considering that about 10% of PDAC have a genetic cause and a genetic counselling is mandatory to correctly treat all the BRCA1/2 germline mutation carriers. This evidence concerns the gene BRCA1 and neoplasm.